These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Tamboli P; Amin MB; Xu HJ; Linden MD Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470 [TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Myers RB; Kudlow JE; Grizzle WE Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115 [TBL] [Abstract][Full Text] [Related]
8. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433 [TBL] [Abstract][Full Text] [Related]
9. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Maygarden SJ; Novotny DB; Moul JW; Bae VL; Ware JL Mod Pathol; 1994 Dec; 7(9):930-6. PubMed ID: 7892162 [TBL] [Abstract][Full Text] [Related]
12. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype. Garcia FU; Haber MM; Chen X Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949 [TBL] [Abstract][Full Text] [Related]
13. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
14. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227 [TBL] [Abstract][Full Text] [Related]
15. c-met proto-oncogene expression in benign and malignant human prostate tissues. Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of ras p21: staining in benign and malignant prostate tissue. Bushman EC; Nayak RN; Bushman W J Urol; 1995 Jan; 153(1):233-7. PubMed ID: 7526005 [TBL] [Abstract][Full Text] [Related]
17. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases. Zhao J; Epstein JI Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840 [TBL] [Abstract][Full Text] [Related]
20. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]